339 related articles for article (PubMed ID: 10789662)
21. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity].
Ruilope LM; Coca A
Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545
[No Abstract] [Full Text] [Related]
22. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
23. Arthritis. Should you be taking a COX-2 inhibitor?
Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
[No Abstract] [Full Text] [Related]
24. [Questions to Professor Jean-François Bretagne].
Bretagne JF
Gastroenterol Clin Biol; 2003 May; 27(5):518-21. PubMed ID: 12843914
[No Abstract] [Full Text] [Related]
25. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
26. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
[No Abstract] [Full Text] [Related]
27. The new NSAIDs: cox-2 inhibitors.
Capriotti T
Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
[No Abstract] [Full Text] [Related]
28. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824
[No Abstract] [Full Text] [Related]
29. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors.
Buttgereit F; Burmester GR; Simon LS
Am J Med; 2001 Feb; 110 Suppl 3A():13S-9S. PubMed ID: 11173045
[TBL] [Abstract][Full Text] [Related]
30. Visual disturbance associated with celecoxib.
Lund BC; Neiman RF
Pharmacotherapy; 2001 Jan; 21(1):114-5. PubMed ID: 11191731
[TBL] [Abstract][Full Text] [Related]
31. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
Wynn RL
Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
[No Abstract] [Full Text] [Related]
32. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
33. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
Hinz B; Brune K
MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
[No Abstract] [Full Text] [Related]
34. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
35. Selective celecoxib-associated anaphylactoid reaction.
Gagnon R; Julien M; Gold P
J Allergy Clin Immunol; 2003 Jun; 111(6):1404-5. PubMed ID: 12789245
[No Abstract] [Full Text] [Related]
36. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582
[No Abstract] [Full Text] [Related]
37. The coxibs, selective inhibitors of cyclooxygenase-2.
Rich SA
N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
[No Abstract] [Full Text] [Related]
38. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
39. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
40. [Therapy with preferential and specific COX-2 inhibitors].
Stichtenoth DO; Frölich JC
Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
